These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36980627)

  • 21. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: A systematic review and meta-analysis.
    Anastasio MK; Nolin A; Penvose KN; Lambert K; Li J; Ledbetter L; Davidson BA; Havrilesky LJ; Albright BB
    Gynecol Oncol; 2024 Dec; 191():10-18. PubMed ID: 39305819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery.
    Long X; Li R; Tang Y; Yang L; Zou D
    Front Oncol; 2022; 12():1028842. PubMed ID: 36425559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant radiotherapy for stage I endometrial cancer.
    Kong A; Johnson N; Kitchener HC; Lawrie TA
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003916. PubMed ID: 22513918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base.
    Nasioudis D; Latif NA; Simpkins F; Cory L; Giuntoli RL; Haggerty AF; Morgan MA; Ko EM
    Gynecol Oncol; 2020 Feb; 156(2):315-319. PubMed ID: 31839340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pure pediatric ovarian immature teratomas: The French experience.
    Pavone R; Dijoud F; Galmiche L; Ro V; Hameury F; Sarnacki S; Orbach D; Briandet C; Pasquet M; Bertrand A; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28186. PubMed ID: 31981415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the benefits of postoperative adjuvant chemotherapy
    Li R; Yang G; Tian Y; Tian D
    J Thorac Dis; 2019 Jul; 11(7):3047-3054. PubMed ID: 31463134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant radiotherapy for stage I endometrial cancer.
    Kong A; Johnson N; Kitchener HC; Lawrie TA
    Cochrane Database Syst Rev; 2012 Mar; (3):CD003916. PubMed ID: 22419290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
    Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer.
    Chatterjee S; Chen L; Tergas AI; Burke WM; Hou JY; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Obstet Gynecol; 2016 Jun; 127(6):992-1002. PubMed ID: 27159756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis.
    Pergialiotis V; Liatsou E; Rouvali A; Haidopoulos D; Efthymios D; Liontos M; Rodolakis A; Thomakos N
    Curr Oncol; 2022 Aug; 29(8):5763-5773. PubMed ID: 36005192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Falcetta FS; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT; Rosa DD
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD005342. PubMed ID: 27873308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: A systematic review and meta-analysis.
    Bogani G; Ditto A; Lopez S; Bertolina F; Murgia F; Pinelli C; Chiappa V; Raspagliesi F
    Gynecol Oncol; 2020 Apr; 157(1):293-298. PubMed ID: 31980220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.
    Takada T; Iwase H; Iitsuka C; Nomura H; Sakamoto K; Omatsu K; Takeshima N; Takizawa K
    Int J Gynecol Cancer; 2012 May; 22(4):573-8. PubMed ID: 22398705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.
    Zhao P; Zhen H; Zhao H; Zhao L; Cao B
    BMC Cancer; 2022 Mar; 22(1):328. PubMed ID: 35346117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immature Ovarian Teratoma: When to Give Adjuvant Therapy?
    Faure-Conter C; Pashankar F
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):487-489. PubMed ID: 28859031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience of a 2-day BEP regimen in postsurgical adjuvant chemotherapy of ovarian germ cell tumors.
    Tay SK; Tan LK
    Int J Gynecol Cancer; 2000 Jan; 10(1):13-18. PubMed ID: 11240646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer.
    Zhang T; Guo Q; Zhang Y; Liu Z; Zhou S; Xu S
    J Cancer Res Ther; 2018 Jan; 14(1):139-144. PubMed ID: 29516976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.